Cargando…
Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study
INTRODUCTION: Squamous cell cancer of the vulva is a rare disease with an annual incidence of two to three per 100,000 women. Lymph node metastasis is the most important prognostic factor for the recurrence and survival in vulval carcinoma. MATERIALS AND METHODS: It is a retrospective study of 18 ca...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955039/ https://www.ncbi.nlm.nih.gov/pubmed/24672200 http://dx.doi.org/10.4103/0976-7800.127784 |
_version_ | 1782307528672018432 |
---|---|
author | Deka, Pankaj Barmon, Debabrata Shribastava, Sushrata Kataki, Amal Chandra Sharma, J. D. Bhattacharyya, M. |
author_facet | Deka, Pankaj Barmon, Debabrata Shribastava, Sushrata Kataki, Amal Chandra Sharma, J. D. Bhattacharyya, M. |
author_sort | Deka, Pankaj |
collection | PubMed |
description | INTRODUCTION: Squamous cell cancer of the vulva is a rare disease with an annual incidence of two to three per 100,000 women. Lymph node metastasis is the most important prognostic factor for the recurrence and survival in vulval carcinoma. MATERIALS AND METHODS: It is a retrospective study of 18 cases, operated in our institute from 2006 to 2009 and followed up till July, 2012. These patients were divided into two group of node positive and node negative and compared for recurrence and survival. RESULT: Ten patients had lymph node metastasis and eight had no lymph node metastasis. Recurrence rate was 40% and 12.5% in node positive and negative groups, respectively. Adjuvant radiation when given to node negative bulky tumor showed no recurrence compared to one out of two in the non-irradiated group. Survival was only 25% in node positive recurrent cases. CONCLUSION: Lymph node positivity added a great risk for future recurrence. Prophylactic radiation in node negative, bulky tumor is helpful. |
format | Online Article Text |
id | pubmed-3955039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-39550392014-03-26 Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study Deka, Pankaj Barmon, Debabrata Shribastava, Sushrata Kataki, Amal Chandra Sharma, J. D. Bhattacharyya, M. J Midlife Health Original Article INTRODUCTION: Squamous cell cancer of the vulva is a rare disease with an annual incidence of two to three per 100,000 women. Lymph node metastasis is the most important prognostic factor for the recurrence and survival in vulval carcinoma. MATERIALS AND METHODS: It is a retrospective study of 18 cases, operated in our institute from 2006 to 2009 and followed up till July, 2012. These patients were divided into two group of node positive and node negative and compared for recurrence and survival. RESULT: Ten patients had lymph node metastasis and eight had no lymph node metastasis. Recurrence rate was 40% and 12.5% in node positive and negative groups, respectively. Adjuvant radiation when given to node negative bulky tumor showed no recurrence compared to one out of two in the non-irradiated group. Survival was only 25% in node positive recurrent cases. CONCLUSION: Lymph node positivity added a great risk for future recurrence. Prophylactic radiation in node negative, bulky tumor is helpful. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC3955039/ /pubmed/24672200 http://dx.doi.org/10.4103/0976-7800.127784 Text en Copyright: © Journal of Mid-life Health http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Deka, Pankaj Barmon, Debabrata Shribastava, Sushrata Kataki, Amal Chandra Sharma, J. D. Bhattacharyya, M. Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study |
title | Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study |
title_full | Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study |
title_fullStr | Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study |
title_full_unstemmed | Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study |
title_short | Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study |
title_sort | prognosis of vulval cancer with lymph node status and size of primary lesion: a survival study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955039/ https://www.ncbi.nlm.nih.gov/pubmed/24672200 http://dx.doi.org/10.4103/0976-7800.127784 |
work_keys_str_mv | AT dekapankaj prognosisofvulvalcancerwithlymphnodestatusandsizeofprimarylesionasurvivalstudy AT barmondebabrata prognosisofvulvalcancerwithlymphnodestatusandsizeofprimarylesionasurvivalstudy AT shribastavasushrata prognosisofvulvalcancerwithlymphnodestatusandsizeofprimarylesionasurvivalstudy AT katakiamalchandra prognosisofvulvalcancerwithlymphnodestatusandsizeofprimarylesionasurvivalstudy AT sharmajd prognosisofvulvalcancerwithlymphnodestatusandsizeofprimarylesionasurvivalstudy AT bhattacharyyam prognosisofvulvalcancerwithlymphnodestatusandsizeofprimarylesionasurvivalstudy |